Daxor Corporation Launches BVA Program at Kansas Medical Center

Daxor Corporation expanded its blood volume analysis program to a Kansas medical center, offering 24-hour turnaround via its Tennessee-based lab. The company reported no upfront costs or onsite lab requirements. No financial results or adoption metrics were disclosed.

Original reporting
Published Nov 17, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 1:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Daxor Corporation Launches BVA Program at Kansas Medical Center — source image
Decision brief

The 30-second read

Low
01

Why it matters

The article signals continued commercial rollout at an academic medical center, but it does not provide adoption metrics, pricing, or financial guidance to quantify impact.

02

Market read

Traders get a commercialization update, but there is no disclosed scale or financial effect to drive a clear repricing catalyst.

03

What to watch

Key missing items include utilization rates, contract terms, reimbursement status, and whether the 24-hour turnaround changes ordering behavior.

Relevance 4/10Novelty 4/10Timing: today, PR-style update with no disclosed financials or adoption metrics

Background

Daxor is expanding its blood volume analysis offering through its ezBVA Lab, positioning the program as a centralized diagnostic service.

Market effects

Suggests incremental growth in centralized diagnostic services, but provides no measurable demand or reimbursement details.

Expands Daxor’s Midwest footprint via a Kansas academic medical center, potentially improving regional access to its testing workflow.

Limited, as the update is geographically specific and lacks scale metrics.

Counterpoint

Without test volumes, payer coverage, or revenue impact, the expansion may not translate into near-term financial momentum.

Key entities

  • Daxor Corporation

    Launched a blood volume analysis program at a Kansas medical center, expanding its Midwest footprint via its ezBVA Lab.

Related articles

$DXRMedAI 8/10

Daxor presents clinical data on blood volume analysis technology

Daxor Corporation (DXR) presented clinical data at the Heart Failure Society of America 2026 Annual Scientific Meeting, showing its blood volume analysis (BVA) technology improved patient outcomes in heart failure studies. The BVA system, FDA-cleared with over 95% accuracy, identified fluid issues and guided treatment. The company has operated for 50 years and holds ISO certification.

$DXRMedAI 8/10

Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor

Daxor Corporation (Nasdaq: DXR) said the USPTO issued U.S. Patent No. 12,635,917 B2 for a “Remote Blood Volume Monitor.” The patent covers systems for continuous, remote tracking of absolute blood volume after a baseline test by combining Daxor blood-volume algorithms with subsequent hematocrit monitoring, including non-invasive wearable optical sensors (e.g., PPG). Daxor said it targets conditions such as heart failure, syncope, anemia, and polycythemia.

$NNVCMed

NanoViricides, Inc. Has Filed its Quarterly Report - Broad-Spectrum Antiviral Drug NV-387 Oral Gummies Has Entered Two Separate Phase II Clinical Trials - One to Treat Ebola Bundibugyo Virus Disease, and Another to Treat Mpox

NanoViricides, Inc. (NYSE American:NNVC) filed its Q3 2026 report, revealing Phase II trials for NV-387 Oral Gummies to treat Ebola and Mpox. The company has $2.98M in cash and $9.56M in total assets, but warns of insufficient funding for operations beyond November 2027.

$UBERMed

Kohl’s products now available for delivery on Uber Eats

Uber (UBER) and Kohl's (KSS) partnered to offer Kohl's products via Uber Eats, covering 1,100+ U.S. stores. Items include apparel, home goods, and Sephora beauty products. The service launches before the holiday season, with a $10 discount on first orders over $50 until December 3, 2026. Kohl's operates 1,100+ stores in 49 states.

$SPCBMed

SuperCom Wins 2nd Electronic Monitoring Contract in Indiana, Fully Displacing Incumbent Provider

SuperCom (SPCB) won its second electronic monitoring contract in Indiana, replacing an incumbent provider. The deal involves deploying its PureSecurity suite, with rollout starting in December 2026. The company reported a trailing twelve-month EBITDA of approximately $12.1 million through Q3 2026, citing over 50 new U.S. contracts and 20 national project wins in Europe since mid-2024.